AP NEWS
Click to copy
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from NewMediaWire
Press release content from NewMediaWire. The AP news staff was not involved in its creation.

NutraLife BioSciences (OTCQB: NLBS) Delivers 30,000 NutraDerma Bug Patch Mosquito Relief Patches to the Bahamas After Hurricane Dorian

September 13, 2019

Coconut Creek, FL - ( NewMediaWire ) - September 13, 2019 - A NutraLife BioSciences representative, along with several other volunteers from South Florida, delivered 30,000 mosquito repellent patches and other relief supplies from South Florida to the Bahamas on September 7 to aid in the recovery from Hurricane Dorian. In addition to 30,000 NutraDerma mosquito relief patches donated by NutraLife BioSciences, the volunteers delivered items including medicine, medical supplies, diapers, food, water, hygiene kits, flashlights, tents, and propane cooking devices.  The supplies arrived at 10:00 am and were immediately distributed to residents of Freeport, Bahamas.

Hurricane Dorian caused large scale destruction in the northwestern Bahamas, with Grand Bahama and the Abaco Islands being the most significantly affected. The death toll remains unknown and thousands are missing. At least 50,000 Bahamians are homeless as a result of the storm.

Among the many health risks posed by Hurricane Dorian is mosquito infestation. Hurricane Dorian resulted in widespread flooding and provided a breeding environment for mosquitoes carrying possibly dangerous and life-threatening diseases.   

Edgar Ward, the Chief Executive Officer of NutraLife BioSciences, stated, “We hope that the 30,000 mosquito patches help residents avoid mosquito bites. Our patches are all-natural, with no side effects or harmful ingredients.  As a South Florida company, our hearts go out to our neighbors in the Bahamas. We hope our efforts will provide much-needed relief and help our neighbors, colleagues, and all those impacted by Hurricane Dorian begin the long process of recovery as they work to put their lives and communities back together. We will continue to monitor relief efforts in the Bahamas and provide assistance to our neighbors.”

Stock Symbol: OTCQB: NLBS | Coconut Creek, FL. 33073 | 888.509.8901

This communication contains statements of a forward-looking nature about NutraLife BioSciences, Inc., and its wholly owned subsidiary, NutraDerma Technologies, Inc. (collectively the “Company”). These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that Company’s current expectations and projections concerning its ability to commercialize the patented insect dermal patch are accurate. All forward-looking statements in this packet of information are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission on April 2, 2019. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

About the Company:

Since the Company was founded in 2010, it has evolved into a branded and private label developer, manufacturer, and distributor of a wide range of nutraceutical, wellness, and CBD products.  The Company started with three nutraceutical spray products in 2010. Since then, the Company has evolved into an FDA registered manufacturer of a wide range of life science products that include seventeen (17) different core formulations with over 50 different variations.  The Company’s products include:

·   Cannabinoid-rich hemp oil derived from industrial hemp

·   Nutraceutical Sprays and Tinctures with CBD as an added ingredient

·   Topical lotions and oils applied directly to the skin 

·   Cosmetics and Skin Care including a CBD product line

·   CBD and other pet products as a dietary supplement

·   All-natural effective mosquito relief patches

Company Contact:

NutraLife BioSciences, Inc.

6601 Lyons Road, Suite L-6

Coconut Creek, FL  33073

Telephone 888-509-8901

www.NutraLifeBioSciences.com

Legal Contact:

Brenda Hamilton, Esq

Hamilton Associates Law Group

101 Plaza Real S, Suite 202 N

Boca Raton Fl 33432

561-416-8956

www.securitieslawyer101.com

All contents © copyright 2019 The Associated Press. All rights reserved.